Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5518498> ?p ?o }
Showing triples 1 to 43 of
43
with 100 triples per page.
- Q5518498 subject Q7162167.
- Q5518498 subject Q8256003.
- Q5518498 subject Q8420198.
- Q5518498 subject Q8431759.
- Q5518498 abstract "Galeterone (TOK-001 or VN/124-1) is a novel steroidal antiandrogen under development by Tokai Pharmaceuticals for the treatment of prostate cancer. It possesses a unique dual mechanism of action, acting as both an androgen receptor antagonist and an inhibitor of CYP17A1, an enzyme required for the biosynthesis of the androgens. It shows selectivity for 17,20-lyase over 17-hydroxylase.As of 2016, galeterone is being compared to enzalutamide in a phase III clinical trial (ARMOR3-SV) for AR-V7-expressing metastatic castration-resistant prostate cancer.".
- Q5518498 casNumber "851983-85-2".
- Q5518498 iupacName "17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3β-ol".
- Q5518498 pubchem "11188409".
- Q5518498 thumbnail Galeterone.svg?width=300.
- Q5518498 wikiPageWikiLink Q14873015.
- Q5518498 wikiPageWikiLink Q14905207.
- Q5518498 wikiPageWikiLink Q15408409.
- Q5518498 wikiPageWikiLink Q177911.
- Q5518498 wikiPageWikiLink Q181257.
- Q5518498 wikiPageWikiLink Q1996756.
- Q5518498 wikiPageWikiLink Q21098941.
- Q5518498 wikiPageWikiLink Q21098975.
- Q5518498 wikiPageWikiLink Q30612.
- Q5518498 wikiPageWikiLink Q321431.
- Q5518498 wikiPageWikiLink Q3271540.
- Q5518498 wikiPageWikiLink Q410943.
- Q5518498 wikiPageWikiLink Q427492.
- Q5518498 wikiPageWikiLink Q574820.
- Q5518498 wikiPageWikiLink Q62614.
- Q5518498 wikiPageWikiLink Q6581305.
- Q5518498 wikiPageWikiLink Q7162167.
- Q5518498 wikiPageWikiLink Q7180990.
- Q5518498 wikiPageWikiLink Q8047.
- Q5518498 wikiPageWikiLink Q8256003.
- Q5518498 wikiPageWikiLink Q8420198.
- Q5518498 wikiPageWikiLink Q8431759.
- Q5518498 wikiPageWikiLink Q851162.
- Q5518498 casNumber "851983".
- Q5518498 iupacName "17".
- Q5518498 pubchem "11188409".
- Q5518498 type ChemicalSubstance.
- Q5518498 type Drug.
- Q5518498 type ChemicalObject.
- Q5518498 type Thing.
- Q5518498 type Q8386.
- Q5518498 comment "Galeterone (TOK-001 or VN/124-1) is a novel steroidal antiandrogen under development by Tokai Pharmaceuticals for the treatment of prostate cancer. It possesses a unique dual mechanism of action, acting as both an androgen receptor antagonist and an inhibitor of CYP17A1, an enzyme required for the biosynthesis of the androgens.".
- Q5518498 label "Galeterone".
- Q5518498 depiction Galeterone.svg.